R Begolli, N Sideris, A Giakountis - Cancers, 2019 - mdpi.com
During the last decade, high-throughput sequencing efforts in the fields of transcriptomics and epigenomics have shed light on the noncoding part of the transcriptome and its …
Historically, the long-held protein-centered bias has denoted 98% of the human genome as 'Junk'DNA. However, the current work has shifted the perception of such'junk'transcriptional …
D Tomar, AS Yadav, D Kumar, G Bhadauriya… - … et Biophysica Acta (BBA …, 2020 - Elsevier
Paradigm shifting studies especially involving non-coding RNAs (ncRNAs) during last few decades have significantly changed the scientific perspectives regarding the complexity of …
Background: Breast cancer (BC) is the most common cancer in women. The incidence and morbidity of BC are expected to rise rapidly. The stage at which BC is diagnosed has a …
CACX is one of the most common cancer affecting women world-wide. Here, expression microarray analysis revealed 8 over-expressed transcribed pseudogenes (GBP1P1, HLA …
A Bahrami, MM Binabaj, GA Ferns - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Exosomes are small cell derived membrane nano-vesicles that carry various components including lipids, proteins and nucleic acids. There is accumulating evidence that exosomes …
XX Li, LJ Wang, J Hou, HY Liu, R Wang… - BioMed research …, 2020 - Wiley Online Library
Breast cancer is the most common cancer observed in adult females, worldwide. Due to the heterogeneity and varied molecular subtypes of breast cancer, the molecular mechanisms …
PY Chen, PL Hsieh, CY Peng, YW Liao, CH Yu… - Journal of the Formosan …, 2021 - Elsevier
Background/Purpose Oral cancer stem cells (CSCs) have been considered as the key cells that are implicated in tumor recurrence and metastasis. In recent years, great attention has …
B Bayarmaa, Z Wu, J Peng, Y Wang, S Xu, T Yan… - BMC cancer, 2019 - Springer
Background Breast cancer is the most common malignancy in women, and neoadjuvant chemotherapy has been recommended to the patients with locally advanced breast cancer …